cancer

AbbVie's 'drip-feed' of patents shields top cancer drug from competition, group says
BioPharma Dive
Wed, 07/15/20 - 11:12 pm
AbbVie
Imbruvcia
patents
cancer
Merck teams up with cancer startup Foghorn in $425M deal
Fierce Biotech
Wed, 07/8/20 - 10:48 am
Merck
Foghorn Therapeutics
cancer
drug development
AI startup Nucleai has immuno-oncology treatment failures in its sights
Pharmaforum
Tue, 07/7/20 - 08:09 pm
Nucleai
artificial intelligence
cancer
Debiopharm
immuno-oncology
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Xconomy
Thu, 06/25/20 - 10:45 am
Relay Therapeutics
IPOs
protein motion
cancer
Bayer Settles Roundup Lawsuit for Almost $11 Billion
Motley Fool
Wed, 06/24/20 - 11:45 pm
Bayer
Roundup
cancer
AstraZeneca first to join FDA's push for patient-reported symptoms in cancer trials
Fierce Pharma
Wed, 06/24/20 - 11:23 am
AstraZeneca
patients
clinical trials
FDA
cancer
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
MedCity News
Tue, 06/23/20 - 11:35 pm
ArcherDX
M&A
IPOs
cancer
Invitae
Sanofi's fight for a better research reputation
BioPharma Dive
Tue, 06/23/20 - 11:34 pm
Sanofi
R&D
cancer
immune disorders
Merck KGaA’s ATR cancer drug cleared for further trials after phase 1 trial success
Pharmaforum
Tue, 06/23/20 - 10:46 am
Merck KGaA
cancer
clinical trials
DNA repair
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Mon, 06/22/20 - 08:37 pm
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer
Xconomy
Wed, 06/17/20 - 09:57 pm
Lassen Therapeutics
fibrosis
cancer
Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda
Endpoints
Wed, 06/17/20 - 10:48 am
Merck
Keytruda
Bristol-Myers Squibb
FDA
biomarkers
accelerated approvals
cancer
TMB
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
Tue, 06/16/20 - 10:56 am
GSK
cancer
R&D
oncology
Ideaya
genome editing
AbbVie to pay Genmab $750M upfront to form bispecific R&D pact
Fierce Biotech
Wed, 06/10/20 - 11:01 am
AbbVie
bispecific antibodies
cancer
Genmab
Regeneron
epcoritamab
Eight Fraudulent Cancer Research Studies Contained The Same Copied Results. How Does This Happen?
Forbes
Tue, 06/9/20 - 11:31 pm
cancer
oncology
academic research
research fraud
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
BioPharma Dive
Fri, 06/5/20 - 11:02 am
Legend Biotech
IPOs
cancer
cell therapies
ASCO 2020
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
Xconomy
Fri, 06/5/20 - 10:51 am
Cullinan Oncology
cancer
oncology
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
AstraZeneca puts $55M into Accent as pharmas continue push to drug RNA
BioPharma Dive
Thu, 06/4/20 - 11:17 am
AstraZeneca
Accent Therapeutics
cancer
RNA
COVID-19 could slow progress in reducing cancer death, NCI head warns
Biopharma Dive
Mon, 06/1/20 - 10:36 am
cancer
cancer deaths
COVID-19
NCI
pandemic

Pages